Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Lung Cancer Screening

폐암 조기 진단

  • Kim, Ju Ock (Department of Internal Medicine, Chungnam National University Hospital & Cancer Research Institute)
  • 김주옥 (충남대학교 의과대학 호흡기내과)
  • Published : 2006.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

기존의 폐암 발생의 고위험군(나이. 흡연력, $FEV_1$, 가족력, 직업적 발암물질의 노출력, 기존의 폐암 및 두경부 종양)에 대한 저선량 나선식 CT와 기관지 내시경 검사로 선별 검사 시 폐암의 유병률은 높아야 2%내외이고 대부분 그보다 낮은 것으로 알려져 있다. 특이도는 49-90%, 양성예측률은 10%이하로 선별검사 시 불필요한 검사를 초래하고 그에 따른 이환률과 사망률을 증가시키며 비용적인 문제를 야기하는 것으로 알려져 있다. 이에 기존의 고위험군에 대해 대상 환자를 더욱 더 좁힐 필요가 있으며, 이는 실제 임상적으로 이용 가능한 생물학적 표지자의 개발의 필요성이 있다고 하겠다. 그러나 현재까지 알려진 폐암조기검진에 대한 각종 진단 수기 중애서 상기의 3가지 방법(저선량 MDCT, 자가형광기관지경 및 객담내 MAGE)을 한꺼번에 시행하는 program은 비용적인 문제는 있지만 시도해 볼 만한 방법이라고 생각된다.

Keywords

References

  1. Humphrey LL, Teutsch S, Johnson MS. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2004:140:740-53 https://doi.org/10.7326/0003-4819-140-9-200405040-00015
  2. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002:20:911-20 https://doi.org/10.1200/JCO.20.4.911
  3. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998:351:1242-5 https://doi.org/10.1016/S0140-6736(97)08229-9
  4. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral ccomputed tomography scanner. Br J Cancer 2001:84:25-32 https://doi.org/10.1054/bjoc.2000.1531
  5. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999:354:99-105 https://doi.org/10.1016/S0140-6736(99)06093-6
  6. Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001:922:153-9
  7. Swensen S, Jett JR, Slon JA, Midthun DE, Hartman TE, Sykes AM, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002:165:508-13 https://doi.org/10.1164/ajrccm.165.4.2107006
  8. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003:226:756-61 https://doi.org/10.1148/radiol.2263020036
  9. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of baseline examinations in 817 asymptomatic smokers. Radiology 2002:222:773-81 https://doi.org/10.1148/radiol.2223010490
  10. Diederich S, Thomas M, Semik M, Lenzen H, Roos N, Weber A, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004:14:691-702 https://doi.org/10.1007/s00330-003-2200-5
  11. Pastorino U, Bellomi M, Landoni C, de Fiori E, Arnaldi P, Picchio M, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003:362:593-597 https://doi.org/10.1016/S0140-6736(03)14188-8
  12. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H, et al. Lung cancer screening using low-dose spiral CT. Chest 2002:122:15-20 https://doi.org/10.1378/chest.122.1.15
  13. Chong SM, Lee KS, Chung MJ, Kjm TS, Kim HJ, Kwon OJ, et al. Lung cancer screening with low-dose helical CT in Korea: experience at the Samsung Medical Center. J Korean Med Sci 2005:20:402-8 https://doi.org/10.3346/jkms.2005.20.3.402
  14. Diederich S, Wormanns D. Impact of low-dose CT on lung cancer screening. Lung Cancer 2004:45:S13-9 https://doi.org/10.1016/j.lungcan.2004.07.997
  15. McWilliams A, Lam S. Lung cancer screening. Curr Opin Pulm Med 2005:11:272-7
  16. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006:61:54-6 https://doi.org/10.1136/thx.2004.037580
  17. Lam S, MacAulay C, le Riche JC, Palcic B. Detection and localization of early lung cancerr by fluorescence bronchoscopy. Cancer 2000:89:2468-73 https://doi.org/10.1002/1097-0142(20001201)89:11+<2468::AID-CNCR25>3.0.CO;2-V
  18. HäuBinger K. Becker H, Stanzel F, Kreuzer A, Schmidt B, Strausz J, et al. Autofluorescence bronchoscopy with light bronchoscopy compared with white light bronchosocpy alone for the detection of precancerous lesions: a European randomized controlled multicentre trial. Thorax 2005:60:496-503 https://doi.org/10.1136/thx.2005.041475
  19. Kennedy TC, Miller Y, Prindiville S. Screening for lung cancer revisited and the role of sptum cytology and fluorescence bronchscopy in a high risk group. Chest 2000:117:72S-9S https://doi.org/10.1378/chest.117.4_suppl_1.72S
  20. McWilliams A, Mayo J, MacDonald S, le Riche JC, Palcic B, Szabo E, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003:168:1167-73 https://doi.org/10.1164/rccm.200301-144OC
  21. Banerjee AK, Rabbitts PH, George J. Flourescence bronchoscopy: clinical dilemmas and reseach opportunities. Thorax 2003:58:266-71 https://doi.org/10.1136/thorax.58.3.266
  22. Sing A, Freudenberg N, Korsik C, Wertzel N, Klosa B, Hasee J. Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lugn cnarcinomas. Acta Cytol 1997:41:399-408 https://doi.org/10.1159/000332531
  23. Kennedy TC, Hirsch FR. Using molecular markers in sputum for the early detection of lung cancer: a review. Lung Cancer 2004:45:S21-7
  24. Thunnissen FB. Sptum examination for early detection of lung cancer. J Clin Pathol 2003:56:805-10 https://doi.org/10.1136/jcp.56.11.805
  25. Huber RM, Statakis DF. Molecular oncology: perspectives in lung cancer. Lung Cancer 2004:45:S209-13 https://doi.org/10.1016/j.lungcan.2004.07.973
  26. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Cleeson K, Greenberg J, et al. Detection of lung cancer with volatile markers in the breath. Chest 2003:123:2115-23 https://doi.org/10.1378/chest.123.6.2115
  27. Jheon S, Hyun DS, Lee SC, Yoon GS, Jeon CH, Park JW, et al. Lung cancer detection by a RT-nested PCR using MAGE A1-6 common primers. Lung Cancer 2004:43:29-37 https://doi.org/10.1016/j.lungcan.2003.08.014
  28. Deppermann KM. Lung cancer screening: where are we in 2004. Lung Cancer 2004:45:S39-42 https://doi.org/10.1016/j.lungcan.2004.07.994
  29. Ashton RW, Jett JR. Screening for non-small cell lung cancer. Semin Oncol 2005:32:253-8 https://doi.org/10.1053/j.seminoncol.2005.02.012
  30. MacRedmond R, McVey G, Lee M, Costello RW, Kenny D, Foley C, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax 2006:61:54-6 https://doi.org/10.1136/thx.2004.037580
  31. Breuer RH, Pasic A, Smit EF, van Vliet E, Vonk Noordegraaf A, Risse EJ, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 2005:11:537-43